177lu-dotatoc
Showing 1 - 6 of 6
Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)
Not yet recruiting
- Neuroendocrine Tumors
- +2 more
- 177Lu-DOTATOC
- (no location specified)
Sep 13, 2023
Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)
Not yet recruiting
- Neuroendocrine Tumors
- +6 more
- 177Lu-DOTATOC
-
Vancouver, British Columbia, CanadaBC Cancer
Aug 19, 2022
Neuroendocrine Tumors Trial in Sweden (177Lu-DOTATOC, Capecitabine)
Not yet recruiting
- Neuroendocrine Tumors
- 177Lu-DOTATOC
- Capecitabine
-
Göteborg, Sweden
- +3 more
May 19, 2022
Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,
Not yet recruiting
- Neuroendocrine Neoplasia's (NENs)
- Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
- 161Tb-DOTA-LM3
- 177Lu-DOTATOC
-
Basel, SwitzerlandDivision of Nuclear Medicine, University Hospital Basel
Apr 27, 2022
Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)
Recruiting
- Pulmonary Neuroendocrine Neoplasm
- +9 more
- 177Lu-DOTATOC
-
Houston, TexasExcel Diagnostics and Nuclear Oncology Center
Jul 9, 2021
Neuroendocrine Tumors Trial in Warszawa (177Lu-DOTATOC)
Unknown status
- Neuroendocrine Tumors
- 177Lu-DOTATOC
-
Warszawa, PolandCentrum Diagnostyczno-Lecznicze Gammed
Nov 2, 2020